Amarin
$16.109876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$16.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.62 (4.02%) Today
+$0.05 (0.31%) As of 7:34 PM EDT after-hours
Why Robinhood?
You can buy or sell Amarin and other stocks, options, ETFs, and crypto commission-free!
About AMRN
Amarin Corporation plc, also called Amarin, is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Read More It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
Employees
530
Headquarters
Dublin, Dublin
Founded
1989
Market Cap
5.32B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
11.21M
High Today
$16.23
Low Today
$15.50
Open Price
$15.50
Volume
8.32M
52 Week High
$23.91
52 Week Low
$2.65
Collections
AMRN News
Price Paid on Robinhood
8% Higher
Right Now
52 Week Low
$2.35
Average Price Paid
$14.87
52 Week High
$23.34
Analyst Ratings
100%
of 6 ratings
Buy
100%
Hold
0%
Sell
0%
AMRN Earnings
-$0.12
-$0.08
-$0.05
-$0.01
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Oct 30, Pre-Market